New prognostic parameters for chronic myelomonocytic leukemia.

Onida et al recently reported on prognostic parameters in chronic myelomonocytic leukemia (CMML) and proposed a new M. D. Anderson prognostic score (MDAPS).[1][1] In a large independent data- base, they essentially confirmed the clinical, laboratory, cytogenetic, and prognostic findings that have

[1]  M. Worwood,et al.  Autosomal dominant reticuloendothelial iron overload associated with a 3-base pair deletion in the ferroportin 1 gene (SLC11A3). , 2002, Blood.

[2]  Terry L. Smith,et al.  Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients. , 2002, Blood.

[3]  A. Donovan,et al.  Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene. , 2001, The Journal of clinical investigation.

[4]  Cornelia M. van Duijn,et al.  A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis , 2001, Nature Genetics.

[5]  U. Germing,et al.  Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. , 2000, Leukemia research.

[6]  S. Abboud,et al.  A Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism* , 2000, The Journal of Biological Chemistry.

[7]  A. Brownlie,et al.  Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter , 2000, Nature.

[8]  U. Germing,et al.  Problems in the classification of CMML--dysplastic versus proliferative type. , 1998, Leukemia research.

[9]  A. Duhamel,et al.  Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. , 1993, Leukemia.

[10]  U. Germing,et al.  Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system. , 1992, Leukemia.

[11]  M. Sanz,et al.  Chronic myelomonocytic leukemia — clinicobiological characteristics: A multivariate analysis in a series of 70 cases , 1989, European journal of haematology.

[12]  R. Beuscart,et al.  Prognostic factors in adult chronic myelomonocytic leukemia: an analysis of 107 cases. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Mufti,et al.  Prognostic features of chronic myelomonocytic leukaemia: a modified Bournemouth score gives the best prediction of survival , 1988, British journal of haematology.

[14]  R. Simon.  Importance of prognostic factors in cancer clinical trials. , 1984, Cancer treatment reports.

[15]  J. Tripp,et al.  Magnetic-susceptibility measurement of human iron stores. , 1982, The New England journal of medicine.